Literature DB >> 17978301

More on severe cutaneous reaction with radiotherapy and cetuximab.

James A Bonner, Kian Ang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17978301     DOI: 10.1056/NEJMc076359

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

Review 1.  Folliculitis induced by EGFR inhibitors, preventive and curative efficacy of tetracyclines in the management and incidence rates according to the type of EGFR inhibitor administered: a systematic literature review.

Authors:  Jean-Baptiste Bachet; Lucie Peuvrel; Claude Bachmeyer; Ziad Reguiai; Pierre A Gourraud; Olivier Bouché; Marc Ychou; Rene J Bensadoun; Brigitte Dreno; Thierry André
Journal:  Oncologist       Date:  2012-03-16

Review 2.  [Therapy with epidermal growth factor receptor inhibitors. Clinical spectrum of cutaneous adverse effects].

Authors:  P A Gerber; B A Buhren; S Kürle; B Homey
Journal:  Hautarzt       Date:  2010-08       Impact factor: 0.751

Review 3.  Future directions in research, treatment and prevention of HPV-related squamous cell carcinoma of the head and neck.

Authors:  Amanda Psyrri; Clarence Sasaki; Maria Vassilakopoulou; George Dimitriadis; Theodoros Rampias
Journal:  Head Neck Pathol       Date:  2012-07-03

4.  The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.

Authors:  William Boland; Gwyn Bebb
Journal:  Biologics       Date:  2010-11-09

Review 5.  Skin toxicities associated with epidermal growth factor receptor inhibitors.

Authors:  Tianhong Li; Roman Perez-Soler
Journal:  Target Oncol       Date:  2009-05-19       Impact factor: 4.493

Review 6.  Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors.

Authors:  L Peuvrel; C Bachmeyer; Z Reguiai; J B Bachet; T André; R J Bensadoun; O Bouché; M Ychou; B Dréno
Journal:  Support Care Cancer       Date:  2012-02-24       Impact factor: 3.359

7.  Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol.

Authors:  Gregor Habl; Alexandra D Jensen; Karin Potthoff; Matthias Uhl; Holger Hof; Jacek Hajda; Christian Simon; Jürgen Debus; Robert Krempien; Marc W Münter
Journal:  BMC Cancer       Date:  2010-11-26       Impact factor: 4.430

8.  Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (head and neck cancer: immunochemo and radiotherapy with erbitux) - a multicenter phase IV trial.

Authors:  G Habl; K Potthoff; M F Haefner; A Abdollahi; J C Hassel; E Boller; M Indorf; J Debus
Journal:  BMC Cancer       Date:  2013-07-15       Impact factor: 4.430

Review 9.  The Therapeutic Potential of Imidazole or Quinone-Based Compounds as Radiosensitisers in Combination with Radiotherapy for the Treatment of Head and Neck Squamous Cell Carcinoma.

Authors:  Abul Azad; Anthony Kong
Journal:  Cancers (Basel)       Date:  2022-09-27       Impact factor: 6.575

10.  Severe skin reaction secondary to concomitant radiotherapy plus cetuximab.

Authors:  Bernhard Berger; Claus Belka
Journal:  Radiat Oncol       Date:  2008-01-28       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.